Evaluation of the Safety and Efficacy of Albumin-bound Docetaxel

Summary

This trial is an open-label, single-center, dose-escalation and cohort-expansion Phase I clinical study in patients with advanced solid tumors. The aim of this study is designed to evaluate the safety, tolerability, pharmacokinetics and preliminary antitumor activity of albumin-bound formulation of docetaxel for intravenous infusion in patients with advanced solid tumors.

Timeline

Start

2020-12-02

Primary completion

2022-12-15

Completion

2023-12-15

Drugs

Indications